Abstract
Twelve adult patients with non-leukaemic lymphoblastic lymphoma were treated with combination chemotherapy and central nervous system prophylaxis according to the protocol developed at Stanford University. Despite strict adherence to the Stanford protocol, 4 of 12 patients relapsed in the CNS, all with meningeal disease. Only four of the 12 patients are in continuing complete remission 6 to 88 months from the completion of induction therapy. These results are inferior to those previously reported for this regimen, and fail to confirm the high rate of control of CNS disease.
Original language | English (US) |
---|---|
Pages (from-to) | 839-841 |
Number of pages | 3 |
Journal | Annals of Oncology |
Volume | 3 |
Issue number | 10 |
DOIs | |
State | Published - Dec 1992 |
Externally published | Yes |
Keywords
- CNS
- Chemotherapy
- Lymphoblastic lymphoma
- Relapse
ASJC Scopus subject areas
- Hematology
- Oncology